Search research articles
Contact Us
Filters
Showing results (91-100 of 147) with videos related to
Page
of 15
Sort By:
Journal of Integrative Neuroscience
|
July 4, 2025
Exercise Leads to Brain Glucose Metabolism Activation, Increased Dopamine D1 Receptor Levels and is Negatively Correlated with Social Behavior
Michael Bobick, Colin Hanna, John Tyler, et al.
INNOSC Theranostics & Pharmacological Sciences
|
August 9, 2024
A historical perspective on clonidine as an alpha-2A receptor agonist in the treatment of addictive behaviors: Focus on opioid dependence
Mark S Gold, Kenneth Blum, Abdalla Bowirrat, et al.
Neurochemical Research
|
November 10, 2025
Chronic Combined Oral Methylphenidate and Fluoxetine Increases Inflammation in Somatosensory and Mesolimbic Brain Regions
Julianna Roeser, Huy Lu, Abigail M Lantry, et al.
Biomedicines
|
April 23, 2022
Frequency of the Dopamine Receptor D3 (rs6280) vs. Opioid Receptor µ1 (rs1799971) Polymorphic Risk Alleles in Patients with Opioid Use Disorder: A Preponderance of Dopaminergic Mechanisms?
Marjorie C Gondré-Lewis, Igor Elman, Tanya Alim, et al.
Acta Scientific Neurology
|
August 9, 2024
Hemiplegic Migraines Exacerbated using an Injectable GLP-1 Agonist for Weight Loss
Edward J Modestino, Abdalla Bowirrat, Kai-Uwe Lewandrowski, et al.
Journal of Addiction Psychiatry
|
August 10, 2023
Psychostimulants for Children: Are We Over or Under Dosing?
Kenneth Blum, Catherine Dennen, Paul R Carney, et al.
Open Journal of Immunology
|
November 21, 2022
Hypothesizing That Pediatric Autoimmune Neuropsychiatric Associated Streptococcal (PANDAS) Causes Rapid Onset of Reward Deficiency Syndrome (RDS) Behaviors and May Require Induction of "Dopamine Homeostasis"
Kenneth Blum, Catherine A Dennen, Eric R Braverman, et al.
Acta Scientific Neurology
|
March 8, 2021
Should We Embrace the Incorporation of Genetically Guided "Dopamine Homeostasis" in the Treatment of Reward Deficiency Syndrome (RSD) as a Frontline Therapeutic Modality?
Kenneth Blum, Ali Raza, Tiffany Schultz, et al.
International Journal of Environmental Research and Public Health
|
January 11, 2022
Hypothesizing in the Face of the Opioid Crisis Coupling Genetic Addiction Risk Severity (GARS) Testing with Electrotherapeutic Nonopioid Modalities Such as H-Wave Could Attenuate Both Pain and Hedonic Addictive Behaviors
Ashim Gupta, Abdalla Bowirrat, Luis Llanos Gomez, et al.
Current Psychopharmacology
|
September 1, 2021
Endorphinergic Enhancement Attenuation of Post-traumatic Stress Disorder (PTSD) <i>via</i> Activation of Neuro-immunological Function in the Face of a Viral Pandemic
Kenneth Blum, Edward J Modestino, David Baron, et al.
Page
of 15
Search research articles
Search
Showing results (91-100 of 147) with videos related to
Sort By:
Page
of 15
Journal of Integrative Neuroscience
|
July 4, 2025
Exercise Leads to Brain Glucose Metabolism Activation, Increased Dopamine D1 Receptor Levels and is Negatively Correlated with Social Behavior
Michael Bobick, Colin Hanna, John Tyler, et al.
INNOSC Theranostics & Pharmacological Sciences
|
August 9, 2024
A historical perspective on clonidine as an alpha-2A receptor agonist in the treatment of addictive behaviors: Focus on opioid dependence
Mark S Gold, Kenneth Blum, Abdalla Bowirrat, et al.
Neurochemical Research
|
November 10, 2025
Chronic Combined Oral Methylphenidate and Fluoxetine Increases Inflammation in Somatosensory and Mesolimbic Brain Regions
Julianna Roeser, Huy Lu, Abigail M Lantry, et al.
Biomedicines
|
April 23, 2022
Frequency of the Dopamine Receptor D3 (rs6280) vs. Opioid Receptor µ1 (rs1799971) Polymorphic Risk Alleles in Patients with Opioid Use Disorder: A Preponderance of Dopaminergic Mechanisms?
Marjorie C Gondré-Lewis, Igor Elman, Tanya Alim, et al.
Acta Scientific Neurology
|
August 9, 2024
Hemiplegic Migraines Exacerbated using an Injectable GLP-1 Agonist for Weight Loss
Edward J Modestino, Abdalla Bowirrat, Kai-Uwe Lewandrowski, et al.
Journal of Addiction Psychiatry
|
August 10, 2023
Psychostimulants for Children: Are We Over or Under Dosing?
Kenneth Blum, Catherine Dennen, Paul R Carney, et al.
Open Journal of Immunology
|
November 21, 2022
Hypothesizing That Pediatric Autoimmune Neuropsychiatric Associated Streptococcal (PANDAS) Causes Rapid Onset of Reward Deficiency Syndrome (RDS) Behaviors and May Require Induction of "Dopamine Homeostasis"
Kenneth Blum, Catherine A Dennen, Eric R Braverman, et al.
Acta Scientific Neurology
|
March 8, 2021
Should We Embrace the Incorporation of Genetically Guided "Dopamine Homeostasis" in the Treatment of Reward Deficiency Syndrome (RSD) as a Frontline Therapeutic Modality?
Kenneth Blum, Ali Raza, Tiffany Schultz, et al.
International Journal of Environmental Research and Public Health
|
January 11, 2022
Hypothesizing in the Face of the Opioid Crisis Coupling Genetic Addiction Risk Severity (GARS) Testing with Electrotherapeutic Nonopioid Modalities Such as H-Wave Could Attenuate Both Pain and Hedonic Addictive Behaviors
Ashim Gupta, Abdalla Bowirrat, Luis Llanos Gomez, et al.
Current Psychopharmacology
|
September 1, 2021
Endorphinergic Enhancement Attenuation of Post-traumatic Stress Disorder (PTSD) <i>via</i> Activation of Neuro-immunological Function in the Face of a Viral Pandemic
Kenneth Blum, Edward J Modestino, David Baron, et al.
Page
of 15